QLSF Biotherapeutics
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
QLSF Biotherapeutics is a biotechnology company that develops antibody-based therapeutics for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QLSF Biotherapeutics Comparables
Compare QLSF Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EpimAb Biotherapeutics | 81% | |
| ABL Bio, Inc. | 76% | |
| BioNTech SE | 73% |
QLSF Biotherapeutics Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 41% MoM, reaching 2K.
- Dec 9, 2025
Monthly visitors increased 67% MoM, from 724 to 1.2K.
QLSF Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about QLSF Biotherapeutics's valuation, stock price, and market status.
Is QLSF Biotherapeutics a public or private company?
QLSF Biotherapeutics is a private company.
What is the current stock price of QLSF Biotherapeutics?
QLSF Biotherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is QLSF Biotherapeutics worth (valuation)?
Valuation information for QLSF Biotherapeutics is not publicly available.
Can I buy QLSF Biotherapeutics stock?
QLSF Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was QLSF Biotherapeutics's last funding round?
Funding round information for QLSF Biotherapeutics is not publicly available.
Who are the main investors in QLSF Biotherapeutics?
Investor information for QLSF Biotherapeutics is not publicly disclosed.
Will QLSF Biotherapeutics IPO soon?
No public IPO plans have been announced for QLSF Biotherapeutics.
How can I track QLSF Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor QLSF Biotherapeutics's secondary market activity and sign up for updates.